Lisdexamfetamine Dimesylate Suppliers & Bulk Manufacturers
Available Forms: Tablets, Capsules
Available Strengths: 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg
Reference Brands: Vyvanse (USA)
Category:
Neurology
Lisdexamfetamine Dimesylate is available in Tablets, Capsules
and strengths such as 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Lisdexamfetamine Dimesylate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Lisdexamfetamine Dimesylate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Lisdexamfetamine dimesylate is a central nervous system stimulant used primarily for the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults. It is also approved for the management of moderate-to-severe binge eating disorder in adults. As a prodrug of dextroamphetamine, lisdexamfetamine is converted to its active form in the body, allowing for a gradual onset of action and sustained therapeutic effects. This mechanism helps reduce the potential for abuse compared to immediate-release amphetamines and supports consistent symptom control over the day.
Lisdexamfetamine helps improve focus, attention, and impulse control in individuals with ADHD, while also reducing binge-eating episodes in adults with binge eating disorder. It is administered orally and is available in capsule, chewable tablet, and oral solution formulations, depending on patient needs. Off-label uses are similar to other pharmaceutical amphetamines, including the treatment of narcolepsy. Clinical studies have demonstrated its effectiveness in adults, with lisdexamfetamine recognized as one of the most effective treatments for adult ADHD. Its use requires medical supervision to monitor efficacy, dosing, and potential side effects.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing